全文获取类型
收费全文 | 1625篇 |
免费 | 116篇 |
国内免费 | 5篇 |
出版年
2022年 | 14篇 |
2021年 | 26篇 |
2020年 | 10篇 |
2019年 | 14篇 |
2018年 | 21篇 |
2017年 | 10篇 |
2016年 | 36篇 |
2015年 | 84篇 |
2014年 | 86篇 |
2013年 | 102篇 |
2012年 | 121篇 |
2011年 | 113篇 |
2010年 | 63篇 |
2009年 | 64篇 |
2008年 | 94篇 |
2007年 | 95篇 |
2006年 | 84篇 |
2005年 | 72篇 |
2004年 | 72篇 |
2003年 | 47篇 |
2002年 | 50篇 |
2001年 | 40篇 |
2000年 | 42篇 |
1999年 | 38篇 |
1998年 | 13篇 |
1997年 | 16篇 |
1996年 | 12篇 |
1995年 | 11篇 |
1994年 | 10篇 |
1993年 | 8篇 |
1992年 | 29篇 |
1991年 | 23篇 |
1990年 | 27篇 |
1989年 | 19篇 |
1988年 | 17篇 |
1987年 | 22篇 |
1986年 | 13篇 |
1985年 | 9篇 |
1984年 | 9篇 |
1983年 | 12篇 |
1982年 | 16篇 |
1981年 | 12篇 |
1980年 | 4篇 |
1979年 | 10篇 |
1978年 | 9篇 |
1977年 | 8篇 |
1976年 | 5篇 |
1975年 | 5篇 |
1974年 | 8篇 |
1972年 | 4篇 |
排序方式: 共有1746条查询结果,搜索用时 15 毫秒
71.
Kuo-Chen Wei Po-Chun Chu Hay-Yan Jack Wang Chiung-Yin Huang Pin-Yuan Chen Hong-Chieh Tsai Yu-Jen Lu Pei-Yun Lee I-Chou Tseng Li-Ying Feng Peng-Wei Hsu Tzu-Chen Yen Hao-Li Liu 《PloS one》2013,8(3)
The purpose of this study is to assess the preclinical therapeutic efficacy of magnetic resonance imaging (MRI)-monitored focused ultrasound (FUS)-induced blood-brain barrier (BBB) disruption to enhance Temozolomide (TMZ) delivery for improving Glioblastoma Multiforme (GBM) treatment. MRI-monitored FUS with microbubbles was used to transcranially disrupt the BBB in brains of Fisher rats implanted with 9L glioma cells. FUS-BBB opening was spectrophotometrically determined by leakage of dyes into the brain, and TMZ was quantitated in cerebrospinal fluid (CSF) and plasma by LC-MS\MS. The effects of treatment on tumor progression (by MRI), animal survival and brain tissue histology were investigated. Results demonstrated that FUS-BBB opening increased the local accumulation of dyes in brain parenchyma by 3.8-/2.1-fold in normal/tumor tissues. Compared to TMZ alone, combined FUS treatment increased the TMZ CSF/plasma ratio from 22.7% to 38.6%, reduced the 7-day tumor progression ratio from 24.03 to 5.06, and extended the median survival from 20 to 23 days. In conclusion, this study provided preclinical evidence that FUS BBB-opening increased the local concentration of TMZ to improve the control of tumor progression and animal survival, suggesting its clinical potential for improving current brain tumor treatment. 相似文献
72.
Lin Shian-Ren Lin Chun-Shu Chen Ching-Cheng Tseng Feng-Jen Wu Tsung-Jui Weng Lebin Weng Ching-Feng 《Molecular and cellular biochemistry》2020,469(1-2):119-132
Molecular and Cellular Biochemistry - Pathological cardiac hypertrophy is ultimately accompanied by cardiomyocyte apoptosis. Apoptosis mainly related to calpain-1-mediated apoptotic pathways.... 相似文献
73.
74.
75.
Vertebrate ankyrin-B and ankyrin-G exhibit divergent subcellular localization and function despite their high sequence and structural similarity and common origin from a single ancestral gene at the onset of chordate evolution. Previous studies of ankyrin family diversity have focused on the C-terminal regulatory domain. Here, we identify an ankyrin-B-specific linker peptide connecting the ankyrin repeat domain to the ZU52-UPA module that inhibits binding of ankyrin-B to membrane protein partners E-cadherin and neurofascin 186 and prevents association of ankyrin-B with epithelial lateral membranes as well as neuronal plasma membranes. The residues of the ankyrin-B linker required for autoinhibition are encoded by a small exon that is highly divergent between ankyrin family members but conserved in the ankyrin-B lineage. We show that the ankyrin-B linker suppresses activity of the ANK repeat domain through an intramolecular interaction, likely with a groove on the surface of the ANK repeat solenoid, thereby regulating the affinities between ankyrin-B and its binding partners. These results provide a simple evolutionary explanation for how ankyrin-B and ankyrin-G have acquired striking differences in their plasma membrane association while maintaining overall high levels of sequence similarity. 相似文献
76.
77.
78.
Ya-Lan Chang Chin-Lin Hsieh Yao-Moan Huang Wen-Liang Chiou Yueh-Hsiung Kuo Mei-Hwei Tseng 《Analytical biochemistry》2013
A wide variety of sulfur metabolites play important roles in plant functions. We have developed a precise and sensitive method for the simultaneous measurement of several sulfur metabolites based on liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS) and 34S metabolic labeling of sulfur-containing metabolites in Arabidopsis thaliana seedlings. However, some sulfur metabolites were unstable during the extraction procedure. Our proposed method does not allow for the detection of the important sulfur metabolite homocysteine because of its instability during sample extraction. Stable isotope-labeled sulfur metabolites of A. thaliana shoot were extracted and utilized as internal standards for quantification of sulfur metabolites with LC–MS/MS using S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), methionine (Met), glutathione (GSH), and glutathione disulfide (GSSG) as example metabolites. These metabolites were detected using electrospray ionization in positive mode. Standard curves were linear (r2 > 0.99) over a range of concentrations (SAM 0.01–2.0 μM, SAH 0.002–0.10 μM, Met 0.05–4.0 μM, GSH 0.17–20.0 μM, GSSG 0.07–20.0 μM), with limits of detection for SAM, SAH, Met, GSH, and GSSG of 0.83, 0.67, 10, 0.56, and 1.1 nM, respectively; and the within-run and between-run coefficients of variation based on quality control samples were less than 8%. 相似文献
79.
Wen-Hsing Lin John T.-A. Hsu Shu-Yi Hsieh Chiung-Tong Chen Jen-Shin Song Shih-Chieh Yen Tsu Hsu Cheng-Tai Lu Chun-Hwa Chen Ling-Hui Chou Yung-Ning Yang Ching-Hui Chiu Ching-Ping Chen Ya-Ju Tseng Kuei-Jung Yen Ching-Fang Yeh Yu-Sheng Chao Teng-Kuang Yeh Weir-Torn Jiaang 《Bioorganic & medicinal chemistry》2013,21(11):2856-2867
Preclinical investigations and early clinical trials suggest that FLT3 inhibitors are a viable therapy for acute myeloid leukemia. However, early clinical data have been underwhelming due to incomplete inhibition of FLT3. We have developed 3-phenyl-1H-5-pyrazolylamine as an efficient template for kinase inhibitors. Structure–activity relationships led to the discovery of sulfonamide, carbamate and urea series of FLT3 inhibitors. Previous studies showed that the sulfonamide 4 and carbamate 5 series were potent and selective FLT3 inhibitors with good in vivo efficacy. Herein, we describe the urea series, which we found to be potent inhibitors of FLT3 and VEGFR2. Some inhibited growth of FLT3-mutated MOLM-13 cells more strongly than the FLT3 inhibitors sorafenib (2) and ABT-869 (3). In preliminary in vivo toxicity studies of the four most active compounds, 10f was found to be the least toxic. A further in vivo efficacy study demonstrated that 10f achieved complete tumor regression in a higher proportion of MOLM-13 xenograft mice than 4 and 5 (70% vs 10% and 40%). These results show that compound 10f possesses improved pharmacologic and selectivity profiles and could be more effective than previously disclosed FLT3 inhibitors in the treatment of acute myeloid leukemia. 相似文献
80.
Nai-Wen Fan De-Kuang Hwang Yu-Chieh Ko Fan-Chen Tseng Kuo-Hsuan Hung Catherine Jui-Ling Liu 《PloS one》2013,8(7)